Your browser doesn't support javascript.
loading
Long term treatment with omalizumab in adolescent with refractory solar urticaria.
Iannelli, Mauro; Passanisi, Stefano; Crisafulli, Giuseppe; Arasi, Stefania; Caminiti, Lucia; Zirilli, Giuseppina; Pajno, Giovanni B.
Afiliación
  • Iannelli M; Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", Allergy Unit, University of Messina, Via Consolare Valeria 1, 98124, Messina, ME, Italy.
  • Passanisi S; Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", Allergy Unit, University of Messina, Via Consolare Valeria 1, 98124, Messina, ME, Italy.
  • Crisafulli G; Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", Allergy Unit, University of Messina, Via Consolare Valeria 1, 98124, Messina, ME, Italy.
  • Arasi S; Predictive and Preventive Medicine Research Unit, Multifactorial and Systemic Disease Research Area, Pediatric Allergology Unit, Bambino Gesù Children's Research Hospital (IRCCS), Rome, Italy.
  • Caminiti L; Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", Allergy Unit, University of Messina, Via Consolare Valeria 1, 98124, Messina, ME, Italy.
  • Zirilli G; Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", Allergy Unit, University of Messina, Via Consolare Valeria 1, 98124, Messina, ME, Italy.
  • Pajno GB; Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", Allergy Unit, University of Messina, Via Consolare Valeria 1, 98124, Messina, ME, Italy. giovanni.pajno@unime.it.
Ital J Pediatr ; 47(1): 195, 2021 Sep 28.
Article en En | MEDLINE | ID: mdl-34583772

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Luz Solar / Urticaria / Antialérgicos / Omalizumab Límite: Adult / Female / Humans Idioma: En Revista: Ital J Pediatr Asunto de la revista: PEDIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Luz Solar / Urticaria / Antialérgicos / Omalizumab Límite: Adult / Female / Humans Idioma: En Revista: Ital J Pediatr Asunto de la revista: PEDIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Italia